HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Harry R Büller Selected Research

fibrin fragment D (D-dimer)

1/2015Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care.
12/2014Alternative diagnoses in patients in whom the GP considered the diagnosis of pulmonary embolism.
6/2014Diagnostic outcome management study in patients with clinically suspected recurrent acute pulmonary embolism with a structured algorithm.
4/2014Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study.
9/2013The additional value of the CRP test in patients in whom the primary care physician excluded pulmonary embolism.
7/2012Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
1/2012Safe exclusion of pulmonary embolism using the Wells rule and qualitative D-dimer testing in primary care: prospective cohort study.
10/2010Clinical decision rule and D-dimer have lower clinical utility to exclude pulmonary embolism in cancer patients. Explanations and potential ameliorations.
4/2010Application of a decision rule and a D-dimer assay in the diagnosis of pulmonary embolism.
1/2010Excluding pulmonary embolism in primary care using the Wells-rule in combination with a point-of care D-dimer test: a scenario analysis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Harry R Büller Research Topics

Disease

35Venous Thromboembolism
11/2015 - 03/2002
29Pulmonary Embolism
01/2015 - 02/2002
28Hemorrhage
12/2015 - 07/2002
28Venous Thrombosis (Deep-Vein Thrombosis)
04/2015 - 04/2002
16Neoplasms (Cancer)
12/2015 - 09/2002
16Thrombosis (Thrombus)
01/2015 - 03/2002
5Thromboembolism
06/2013 - 03/2005
5Hyperhomocysteinemia
05/2009 - 10/2004
4Cardiovascular Diseases (Cardiovascular Disease)
09/2015 - 05/2008
4Stroke (Strokes)
09/2015 - 07/2002
4Atrial Fibrillation
09/2015 - 09/2005
4Body Weight (Weight, Body)
10/2013 - 06/2003
4Acute Coronary Syndrome
06/2013 - 03/2002
4Thrombophilia
01/2011 - 05/2009
4Atherosclerosis
07/2009 - 07/2002
3Thrombocytopenia (Thrombopenia)
12/2015 - 08/2011
3Embolism (Embolus)
09/2015 - 02/2002
3Sepsis (Septicemia)
10/2005 - 10/2002
3Myocardial Infarction
09/2004 - 07/2002
2Hypertension (High Blood Pressure)
09/2015 - 07/2009
2Diabetes Mellitus
09/2015 - 02/2012
2Lung Neoplasms (Lung Cancer)
01/2014 - 11/2010
2Hemophilia A (Haemophilia)
02/2011 - 04/2005
2Neoplasm Metastasis (Metastasis)
11/2010 - 04/2010
2Protein S Deficiency (Deficiency, Protein S)
05/2009 - 03/2005
2Human Influenza (Influenza)
01/2007 - 11/2006
2Activated Protein C Resistance (APC Resistance)
07/2006 - 02/2003
2Endotoxemia
07/2006 - 10/2002
2Inflammation
07/2006 - 10/2005
2Peripheral Arterial Disease
03/2003 - 07/2002
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
12/2015
1Coronary Disease (Coronary Heart Disease)
09/2015
1Heart Failure
09/2015
1Right Ventricular Dysfunction
10/2013
1Asthma (Bronchial Asthma)
09/2013
1Subacute Sclerosing Panencephalitis (SSPE)
08/2013
1Hyperthyroxinemia
02/2013
1Hypothyroidism
02/2013
1Hyperaldosteronism (Conn Syndrome)
02/2011
1Pheochromocytoma
02/2011
1Cushing Syndrome
02/2011
1Chronic Disease (Chronic Diseases)
02/2011
1Hyperparathyroidism
02/2011
1Hyperprolactinemia
02/2011
1Habitual Abortion (Recurrent Miscarriage)
04/2010

Drug/Important Bio-Agent (IBA)

24fibrin fragment D (D-dimer)IBA
01/2015 - 02/2002
17Heparin (Liquaemin)FDA LinkGeneric
12/2015 - 03/2002
17Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
11/2015 - 03/2002
15Vitamin KFDA Link
12/2015 - 06/2003
13AnticoagulantsIBA
12/2015 - 09/2003
10Warfarin (Coumadin)FDA LinkGeneric
09/2015 - 06/2002
9Protein CIBA
08/2011 - 07/2003
9Factor VIII (Coagulation Factor VIII)IBA
02/2011 - 10/2002
8Prothrombin (Factor II)IBA
04/2011 - 07/2002
7Enoxaparin (Lovenox)FDA LinkGeneric
07/2014 - 08/2003
7ThrombinFDA Link
07/2012 - 03/2002
6Factor Xa (Coagulation Factor Xa)IBA
11/2015 - 11/2002
5rivaroxabanIBA
07/2014 - 03/2007
5Deoxycytidine (CDR)IBA
06/2014 - 07/2005
5fondaparinux (Arixtra)FDA Link
06/2013 - 11/2002
5factor V LeidenIBA
04/2011 - 03/2002
4Carboxypeptidase U (TAFI)IBA
02/2013 - 10/2002
4Protein SIBA
08/2011 - 03/2005
4AntibodiesIBA
08/2011 - 03/2003
4Thromboplastin (Tissue Factor)IBA
03/2007 - 10/2002
3edoxabanIBA
11/2015 - 10/2013
3AcenocoumarolIBA
09/2015 - 10/2005
3Factor XI (Plasma Thromboplastin Antecedent)IBA
04/2015 - 10/2002
3Brain Natriuretic Peptide (Natrecor)FDA Link
10/2013 - 11/2004
3idraparinuxIBA
07/2011 - 03/2004
3HormonesIBA
02/2011 - 07/2004
3Carbon MonoxideIBA
06/2010 - 10/2002
3Nadroparin (Nadroparin Calcium)IBA
04/2010 - 04/2005
3Factor VIIa (Activated Factor VII)IBA
07/2006 - 01/2003
3recombinant FVIIa (rFVIIa)IBA
04/2005 - 11/2002
3Dalteparin (Dalteparin Sodium)FDA Link
06/2004 - 03/2002
2SANORG 34006IBA
09/2015 - 07/2011
2CreatinineIBA
09/2015 - 10/2013
2Adrenal Cortex Hormones (Corticosteroids)IBA
09/2013 - 05/2013
2Thyroxine (Levothyroxine)FDA LinkGeneric
02/2013 - 06/2010
2ProlactinIBA
09/2012 - 03/2011
2Glucose (Dextrose)FDA LinkGeneric
02/2012 - 02/2011
2Fibrinolytic Agents (Antithrombotic Agents)IBA
05/2008 - 05/2004
2HomocysteineIBA
08/2007 - 10/2004
1tebufenozide (Mimic)IBA
08/2013
1Estrogens (Estrogen)FDA Link
08/2013
1GlucocorticoidsIBA
05/2013
1Blood Coagulation Factors (Coagulation Factor)IBA
09/2012
1idrabiotaparinuxIBA
01/2012
1A-factor (Streptomyces)IBA
08/2011
1Growth hormone excessIBA
02/2011
1CholesterolIBA
02/2011
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2010
1von Willebrand FactorIBA
08/2009

Therapy/Procedure

2Arthroplasty
01/2015 - 02/2012
2Drug Therapy (Chemotherapy)
01/2014 - 11/2010
2Hip Replacement Arthroplasty (Total Hip Replacement)
09/2007 - 07/2002
2Thrombolytic Therapy
11/2004 - 09/2004
2Aftercare (After-Treatment)
06/2003 - 03/2002
1Subcutaneous Injections
07/2010